A prognostic 15-gene model based on differentially expressed genes among metabolic subtypes in diffuse large B-cell lymphoma

The outcomes of patients with diffuse large B-cell lymphoma (DLBCL) vary widely, and about 40% of them could not be cured by the standard first-line treatment, R-CHOP, which could be due to the high heterogeneity of DLBCL. Here, we aim to construct a prognostic model based on the genetic signature o...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Jun, Guo, Peng, Lu, Yujiao, Jin, Xiaokang, Liang, Ke, Zhao, Na, Xue, Shunxu, Zhou, Chengmin, Wang, Guoqiang, Zhu, Xin, Hong, Huangming, Chen, Yungchang, Lu, Huafei, Wang, Wenxian, Xu, Chunwei, Han, Yusheng, Cai, Shangli, Liu, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pathology and Oncology Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931744/
https://www.ncbi.nlm.nih.gov/pubmed/36816541
http://dx.doi.org/10.3389/pore.2023.1610819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931744/
https://www.ncbi.nlm.nih.gov/pubmed/36816541
http://dx.doi.org/10.3389/pore.2023.1610819

Ejemplares similares